DNAprint Genomics (DNAG)

[chiggah]

GOALS
(Read the last line)

BACKGROUND

THE H. LEE MOFFITT CANCER CENTER

The H. Lee Moffitt Cancer Center - has a substantial program involved in cancer,
has access to a l85,000 patient clinical center and has expertise in the conduct
of clinical trials.

DNAPRINT GENOMICS, INC. - IS A PHARMACOGENOMICS COMPANY WITH PROPRIETARY
TECHNOLOGIES TO STUDY DNA SAMPLES AND DETERMINE CLASSIFIERS TO PREDICT RESPONSES
TO DRUGS.

STUDY PROPOSAL ON COLON CANCER
PRINCIPAL INVESTIGATOR AT MOFFITT: TIM YEATMAN, MD_____________________________

STUDY PROPOSAL ON MULTIPLE MYELOMA
PRINCIPAL INVESTIGATOR AT MOFFITT: DANIEL SULLIVAN, MD__________________________


STUDY PROPOSAL ON CYCLOPHOSPHAMIDE
PRINCIPAL INVESTIGATOR AT MOFFITT: RICHARD M. LUSH, PHD_________________________


STUDY PROPOSAL ON TAXANES
PRINCIPAL INVESTIGATOR AT MOFFITT: JONATHAN M. LANCASTER, MD